EARNINGS PER SHARE

The following tables show the computation of basic and diluted loss per common share for each period presented (in thousands, except per share amounts):



	Three Months Ended						Nine Months Ended
	November 3, 2018			October 28, 2017			November 3, 2018			October 28, 2017
Basic:
Net loss	$	(31,353	)	$	(17,722	)	$	(79,953	)	$	(42,967	)
Distributed earnings allocated to participating securities	(18		)	(66		)	(149		)	(268		)
Net loss allocated to common shares	(31,371		)	(17,788		)	(80,102		)	(43,235		)

Basic weighted average shares outstanding	28,261			27,602			28,059			27,468
Basic loss per share	$	(1.11	)	$	(0.64	)	$	(2.85	)	$	(1.57	)

	Three Months Ended						Nine Months Ended
	November 3, 2018			October 28, 2017			November 3, 2018			October 28, 2017
Diluted:
Net loss	$	(31,353	)	$	(17,722	)	$	(79,953	)	$	(42,967	)
Distributed earnings allocated to participating securities	(18		)	(66		)	(149		)	(268		)
Net loss allocated to common shares	(31,371		)	(17,788		)	(80,102		)	(43,235		)

Basic weighted average shares outstanding	28,261			27,602			28,059			27,468
Dilutive effect of stock awards	—			—			—			—
Diluted weighted average shares outstanding	28,261			27,602			28,059			27,468
Diluted loss per share	$	(1.11	)	$	(0.64	)	$	(2.85	)	$	(1.57	)

The number of shares attributable to outstanding stock-based compensation awards that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):



	Three Months Ended		Nine Months Ended
	November 3, 2018	October 28, 2017	November 3, 2018	October 28, 2017
Number of anti-dilutive shares due to net loss for the period	89	—	341	—
Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock	—	113	19	129